4 completed, 1 recruiting. 2 Phase 4, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Recruiting 1 |
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow ProHance: new trials by email Literature Review of ProHance trials Research Report on ProHance
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years Motor Tests, Cognitive Tests, Unenhanced-MRI of the brain - Motor Function, Cognitive Function | Phase 4 | Recruiting | Guerbet | 2076 | 2021-03-24 | 2026-01-22 |
| Evaluation of Safety and Efficacy of ProHance in Pediatric Patients <2yrs ProHance - Central Nervous System Diseases, Central Nervous System Neoplasms | Completed | Bracco Diagnostics, Inc | 125 | 2018-11-01 | 2020-01-23 | |
| Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging, Ferumoxytol, Gadoteridol - Glioblastoma | Not applicable | Completed | OHSU Knight Cancer Institute | 29 | 2015-01-06 | 2022-03-17 |
| Comparison of Prohance® With Gadovist®/Gadavist™ in Magnetic Resonance Imaging (MRI) of the Brain gadoteridol, gadobutrol - Brain Disease | Phase 4 | Completed | Bracco Diagnostics, Inc | 229 | 2012-08-01 | 2015-07-01 |
| SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study Gadobutrol (Gadavist, Gadovist, BAY86-4875), ProHance - Brain Metastases | Phase 3 | Completed | Bayer | 165 | 2007-08-01 | 2017-08-28 |
Brain Diseases (1) · Brain Neoplasms (1) · Breast Neoplasms (1) · Carcinoma, Hepatocellular (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Colorectal Neoplasms (1) · Glioblastoma (1) · Neuroendocrine Tumors (1) · Prostatic Neoplasms (1)
Bracco Diagnostics, Inc (2) · Bayer (1) · Guerbet (1) · OHSU Knight Cancer Institute (1)
United States (4) · Brazil (1) · Canada (1) · France (1) · Germany (1) · Italy (1) · Japan (1) · Russia (1) · South Korea (1)
Gianpaolo Pirovano, MD (2) · Edward A Neuwelt (1)